HEADER ISOMERASE/ISOMERASE INHIBITOR 31-DEC-14 4XGK TITLE CRYSTAL STRUCTURE OF UDP-GALACTOPYRANOSE MUTASE FROM CORYNEBACTERIUM TITLE 2 DIPHTHERIAE IN COMPLEX WITH 2-[4-(4-CHLOROPHENYL)-7-(2-THIENYL)-2- TITLE 3 THIA-5,6,8,9-TETRAZABICYCLO[4.3.0]NONA-4,7,9-TRIEN-3-YL]ACETIC COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-GALACTOPYRANOSE MUTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 18-404; COMPND 5 EC: 5.4.99.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CORYNEBACTERIUM DIPHTHERIAE; SOURCE 3 ORGANISM_TAXID: 257309; SOURCE 4 STRAIN: ATCC 700971 / NCTC 13129 / BIOTYPE GRAVIS; SOURCE 5 GENE: GLF, DIP2203; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL C5X KEYWDS UDP-GALACTOPYRANOSE MUTASE, CORYNEBACTERIUM DIPHTHERIAE, INHIBITOR, KEYWDS 2 GALACTOFURANOSE, ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.WANGKANONT,A.HEROUX,K.T.FOREST,L.L.KIESSLING REVDAT 6 27-SEP-23 4XGK 1 REMARK REVDAT 5 09-SEP-20 4XGK 1 TITLE REVDAT 4 11-DEC-19 4XGK 1 REMARK REVDAT 3 27-SEP-17 4XGK 1 REMARK REVDAT 2 04-NOV-15 4XGK 1 JRNL REVDAT 1 12-AUG-15 4XGK 0 JRNL AUTH V.A.KINCAID,N.LONDON,K.WANGKANONT,D.A.WESENER,S.A.MARCUS, JRNL AUTH 2 A.HEROUX,L.NEDYALKOVA,A.M.TALAAT,K.T.FOREST,B.K.SHOICHET, JRNL AUTH 3 L.L.KIESSLING JRNL TITL VIRTUAL SCREENING FOR UDP-GALACTOPYRANOSE MUTASE LIGANDS JRNL TITL 2 IDENTIFIES A NEW CLASS OF ANTIMYCOBACTERIAL AGENTS. JRNL REF ACS CHEM.BIOL. V. 10 2209 2015 JRNL REFN ESSN 1554-8937 JRNL PMID 26214585 JRNL DOI 10.1021/ACSCHEMBIO.5B00370 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.77 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 75270 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 3750 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.7790 - 5.7108 1.00 7197 378 0.1534 0.1802 REMARK 3 2 5.7108 - 4.5339 1.00 7196 374 0.1458 0.1869 REMARK 3 3 4.5339 - 3.9611 1.00 7203 374 0.1399 0.1870 REMARK 3 4 3.9611 - 3.5990 1.00 7149 375 0.1871 0.2362 REMARK 3 5 3.5990 - 3.3411 1.00 7146 381 0.2140 0.2798 REMARK 3 6 3.3411 - 3.1442 0.99 7156 373 0.2410 0.2938 REMARK 3 7 3.1442 - 2.9867 0.99 7164 380 0.2516 0.2931 REMARK 3 8 2.9867 - 2.8567 0.99 7138 372 0.2816 0.3570 REMARK 3 9 2.8567 - 2.7468 0.99 7122 379 0.2871 0.3408 REMARK 3 10 2.7468 - 2.6520 0.98 7049 364 0.3073 0.3908 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.450 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 75.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 6761 REMARK 3 ANGLE : 1.300 9201 REMARK 3 CHIRALITY : 0.049 914 REMARK 3 PLANARITY : 0.008 1198 REMARK 3 DIHEDRAL : 16.885 2469 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4XGK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JAN-15. REMARK 100 THE DEPOSITION ID IS D_1000205632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-SEP-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40032 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 9.800 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : 0.79000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 1I8T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS, 2 M AMMONIUM SULFATE, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+1/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.41200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 96.82400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.41200 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 96.82400 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.41200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 96.82400 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 48.41200 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 96.82400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 99 C - N - CA ANGL. DEV. = 17.0 DEGREES REMARK 500 PRO A 99 C - N - CD ANGL. DEV. = -29.1 DEGREES REMARK 500 PRO A 170 C - N - CA ANGL. DEV. = -10.2 DEGREES REMARK 500 PRO B 99 C - N - CA ANGL. DEV. = 18.3 DEGREES REMARK 500 PRO B 99 C - N - CD ANGL. DEV. = -31.6 DEGREES REMARK 500 LEU B 386 CA - CB - CG ANGL. DEV. = 19.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 99 135.39 37.41 REMARK 500 PRO A 170 54.26 -115.79 REMARK 500 ALA A 171 -40.54 66.31 REMARK 500 ASN A 267 38.23 -86.74 REMARK 500 ASN A 267 12.25 -66.83 REMARK 500 GLN A 272 -2.42 -145.17 REMARK 500 GLU A 320 103.63 -37.02 REMARK 500 LYS A 381 -45.39 -143.40 REMARK 500 TYR B 44 121.85 -39.87 REMARK 500 PRO B 49 -76.88 -21.27 REMARK 500 TYR B 83 130.07 -27.44 REMARK 500 PRO B 99 133.97 40.98 REMARK 500 ASP B 133 -140.21 -73.25 REMARK 500 ALA B 134 94.15 68.45 REMARK 500 TYR B 181 40.90 -99.02 REMARK 500 ALA B 208 -72.81 -65.96 REMARK 500 ASP B 209 78.44 -25.37 REMARK 500 VAL B 224 -5.63 -140.22 REMARK 500 ASN B 232 61.20 -115.74 REMARK 500 PHE B 247 43.23 -87.94 REMARK 500 ASP B 248 41.13 38.64 REMARK 500 ARG B 288 138.90 -170.89 REMARK 500 ASP B 379 -76.29 -73.69 REMARK 500 LEU B 382 -86.19 -67.17 REMARK 500 VAL B 383 -34.94 -39.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 98 PRO A 99 -103.77 REMARK 500 PHE B 98 PRO B 99 -106.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 40K A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FDA A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 40K B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FDA B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 408 DBREF 4XGK A 1 387 UNP Q6NER4 Q6NER4_CORDI 18 404 DBREF 4XGK B 1 387 UNP Q6NER4 Q6NER4_CORDI 18 404 SEQADV 4XGK GLY A 0 UNP Q6NER4 EXPRESSION TAG SEQADV 4XGK GLY B 0 UNP Q6NER4 EXPRESSION TAG SEQRES 1 A 388 GLY MET SER ASP PHE ASP LEU ILE VAL VAL GLY SER GLY SEQRES 2 A 388 LEU PHE GLY LEU THR VAL ALA GLU ARG ALA ALA SER GLN SEQRES 3 A 388 LEU GLY LYS LYS VAL LEU ILE VAL GLU LYS ARG SER HIS SEQRES 4 A 388 LEU GLY GLY ASN ALA TYR SER GLU ALA GLU PRO GLU THR SEQRES 5 A 388 GLY ILE GLU ILE HIS LYS TYR GLY ALA HIS LEU PHE HIS SEQRES 6 A 388 THR SER ASN LYS ARG VAL TRP ASP TYR VAL ASN GLN PHE SEQRES 7 A 388 THR ALA PHE THR GLY TYR GLN HIS ARG VAL PHE ALA MET SEQRES 8 A 388 HIS ASN GLY THR ALA TYR GLN PHE PRO MET GLY LEU GLY SEQRES 9 A 388 LEU ILE ASN GLN PHE PHE GLY ARG TYR TYR THR PRO ASP SEQRES 10 A 388 GLU ALA ARG GLU LEU ILE LYS GLU GLN SER ALA GLU ILE SEQRES 11 A 388 ASP SER LYS ASP ALA THR ASN LEU GLU GLU LYS ALA ILE SEQRES 12 A 388 SER LEU ILE GLY ARG PRO LEU TYR GLU ALA PHE ILE ARG SEQRES 13 A 388 ASP TYR THR ALA LYS GLN TRP GLN THR ASP PRO LYS GLU SEQRES 14 A 388 LEU PRO ALA GLY ASN ILE THR ARG LEU PRO VAL ARG TYR SEQRES 15 A 388 ASN PHE ASP ASN ARG TYR PHE ASN ASP THR TYR GLU GLY SEQRES 16 A 388 LEU PRO VAL ASP GLY TYR ALA GLN TRP LEU SER ASN MET SEQRES 17 A 388 ALA ASP HIS GLU ASN ILE GLU VAL ARG LEU ASP THR ASP SEQRES 18 A 388 TRP PHE GLU VAL ARG GLU ASP LEU ARG ALA GLN ASN PRO SEQRES 19 A 388 GLU ALA PRO VAL VAL TYR THR GLY PRO LEU ASP ARG TYR SEQRES 20 A 388 PHE ASP TYR SER GLU GLY HIS LEU GLY TRP ARG THR LEU SEQRES 21 A 388 ASP PHE GLU THR GLU VAL LEU ASN THR GLY ASP PHE GLN SEQRES 22 A 388 GLY THR PRO VAL MET ASN TYR ASN ASP ALA GLU PHE PRO SEQRES 23 A 388 TYR THR ARG ILE HIS GLU PHE ARG HIS PHE HIS PRO GLU SEQRES 24 A 388 ARG GLU ASP ARG HIS PRO LYS ASP LYS THR VAL ILE MET SEQRES 25 A 388 LYS GLU TYR SER ARG PHE ALA GLU GLU GLY ASP GLU PRO SEQRES 26 A 388 TYR TYR PRO ILE ASN THR PRO SER ASP ARG GLU MET LEU SEQRES 27 A 388 PHE LYS TYR ARG GLU LEU ALA ASP ALA GLU THR GLU SER SEQRES 28 A 388 GLY LYS VAL TYR PHE GLY GLY ARG LEU GLY THR TYR GLN SEQRES 29 A 388 TYR LEU ASP MET HIS MET ALA ILE ALA SER ALA LEU SER SEQRES 30 A 388 MET PHE ASP ASN LYS LEU VAL ASP ALA LEU LYS SEQRES 1 B 388 GLY MET SER ASP PHE ASP LEU ILE VAL VAL GLY SER GLY SEQRES 2 B 388 LEU PHE GLY LEU THR VAL ALA GLU ARG ALA ALA SER GLN SEQRES 3 B 388 LEU GLY LYS LYS VAL LEU ILE VAL GLU LYS ARG SER HIS SEQRES 4 B 388 LEU GLY GLY ASN ALA TYR SER GLU ALA GLU PRO GLU THR SEQRES 5 B 388 GLY ILE GLU ILE HIS LYS TYR GLY ALA HIS LEU PHE HIS SEQRES 6 B 388 THR SER ASN LYS ARG VAL TRP ASP TYR VAL ASN GLN PHE SEQRES 7 B 388 THR ALA PHE THR GLY TYR GLN HIS ARG VAL PHE ALA MET SEQRES 8 B 388 HIS ASN GLY THR ALA TYR GLN PHE PRO MET GLY LEU GLY SEQRES 9 B 388 LEU ILE ASN GLN PHE PHE GLY ARG TYR TYR THR PRO ASP SEQRES 10 B 388 GLU ALA ARG GLU LEU ILE LYS GLU GLN SER ALA GLU ILE SEQRES 11 B 388 ASP SER LYS ASP ALA THR ASN LEU GLU GLU LYS ALA ILE SEQRES 12 B 388 SER LEU ILE GLY ARG PRO LEU TYR GLU ALA PHE ILE ARG SEQRES 13 B 388 ASP TYR THR ALA LYS GLN TRP GLN THR ASP PRO LYS GLU SEQRES 14 B 388 LEU PRO ALA GLY ASN ILE THR ARG LEU PRO VAL ARG TYR SEQRES 15 B 388 ASN PHE ASP ASN ARG TYR PHE ASN ASP THR TYR GLU GLY SEQRES 16 B 388 LEU PRO VAL ASP GLY TYR ALA GLN TRP LEU SER ASN MET SEQRES 17 B 388 ALA ASP HIS GLU ASN ILE GLU VAL ARG LEU ASP THR ASP SEQRES 18 B 388 TRP PHE GLU VAL ARG GLU ASP LEU ARG ALA GLN ASN PRO SEQRES 19 B 388 GLU ALA PRO VAL VAL TYR THR GLY PRO LEU ASP ARG TYR SEQRES 20 B 388 PHE ASP TYR SER GLU GLY HIS LEU GLY TRP ARG THR LEU SEQRES 21 B 388 ASP PHE GLU THR GLU VAL LEU ASN THR GLY ASP PHE GLN SEQRES 22 B 388 GLY THR PRO VAL MET ASN TYR ASN ASP ALA GLU PHE PRO SEQRES 23 B 388 TYR THR ARG ILE HIS GLU PHE ARG HIS PHE HIS PRO GLU SEQRES 24 B 388 ARG GLU ASP ARG HIS PRO LYS ASP LYS THR VAL ILE MET SEQRES 25 B 388 LYS GLU TYR SER ARG PHE ALA GLU GLU GLY ASP GLU PRO SEQRES 26 B 388 TYR TYR PRO ILE ASN THR PRO SER ASP ARG GLU MET LEU SEQRES 27 B 388 PHE LYS TYR ARG GLU LEU ALA ASP ALA GLU THR GLU SER SEQRES 28 B 388 GLY LYS VAL TYR PHE GLY GLY ARG LEU GLY THR TYR GLN SEQRES 29 B 388 TYR LEU ASP MET HIS MET ALA ILE ALA SER ALA LEU SER SEQRES 30 B 388 MET PHE ASP ASN LYS LEU VAL ASP ALA LEU LYS HET SO4 A 401 5 HET 40K A 402 25 HET FDA A 403 53 HET SO4 A 404 5 HET SO4 A 405 5 HET SO4 A 406 5 HET SO4 A 407 5 HET SO4 B 401 5 HET 40K B 402 25 HET FDA B 403 53 HET SO4 B 404 5 HET SO4 B 405 5 HET SO4 B 406 5 HET SO4 B 407 5 HET SO4 B 408 5 HETNAM SO4 SULFATE ION HETNAM 40K [(7S)-6-(4-CHLOROPHENYL)-3-(THIOPHEN-2-YL)-7H-[1,2, HETNAM 2 40K 4]TRIAZOLO[3,4-B][1,3,4]THIADIAZIN-7-YL]ACETIC ACID HETNAM FDA DIHYDROFLAVINE-ADENINE DINUCLEOTIDE FORMUL 3 SO4 11(O4 S 2-) FORMUL 4 40K 2(C16 H11 CL N4 O2 S2) FORMUL 5 FDA 2(C27 H35 N9 O15 P2) FORMUL 18 HOH *34(H2 O) HELIX 1 AA1 GLY A 12 LEU A 26 1 15 HELIX 2 AA2 GLY A 40 ALA A 43 5 4 HELIX 3 AA3 ASN A 67 ASN A 75 1 9 HELIX 4 AA4 GLY A 101 GLY A 110 1 10 HELIX 5 AA5 THR A 114 ALA A 127 1 14 HELIX 6 AA6 GLU A 128 ILE A 129 5 2 HELIX 7 AA7 ASP A 130 ALA A 134 5 5 HELIX 8 AA8 ASN A 136 GLY A 146 1 11 HELIX 9 AA9 GLY A 146 ILE A 154 1 9 HELIX 10 AB1 ILE A 154 GLN A 163 1 10 HELIX 11 AB2 ASP A 165 LEU A 169 5 5 HELIX 12 AB3 ASP A 198 ASP A 209 1 12 HELIX 13 AB4 ASP A 220 ASN A 232 1 13 HELIX 14 AB5 PRO A 242 PHE A 247 1 6 HELIX 15 AB6 ARG A 293 GLU A 300 5 8 HELIX 16 AB7 THR A 330 LYS A 352 1 23 HELIX 17 AB8 GLY A 356 TYR A 362 1 7 HELIX 18 AB9 ASP A 366 LYS A 381 1 16 HELIX 19 AC1 LYS A 381 LYS A 387 1 7 HELIX 20 AC2 GLY B 12 GLY B 27 1 16 HELIX 21 AC3 ASN B 67 GLN B 76 1 10 HELIX 22 AC4 GLY B 101 GLY B 110 1 10 HELIX 23 AC5 THR B 114 SER B 126 1 13 HELIX 24 AC6 ASN B 136 GLY B 146 1 11 HELIX 25 AC7 GLY B 146 ILE B 154 1 9 HELIX 26 AC8 ILE B 154 GLN B 163 1 10 HELIX 27 AC9 ASP B 165 LEU B 169 5 5 HELIX 28 AD1 PRO B 170 ILE B 174 5 5 HELIX 29 AD2 GLY B 199 ASP B 209 1 11 HELIX 30 AD3 ASP B 220 ASN B 232 1 13 HELIX 31 AD4 PRO B 242 PHE B 247 1 6 HELIX 32 AD5 ARG B 293 GLU B 300 5 8 HELIX 33 AD6 THR B 330 LYS B 352 1 23 HELIX 34 AD7 GLY B 356 TYR B 362 1 7 HELIX 35 AD8 ASP B 366 LYS B 381 1 16 HELIX 36 AD9 LYS B 381 LEU B 386 1 6 SHEET 1 AA1 5 ILE A 213 ARG A 216 0 SHEET 2 AA1 5 VAL A 30 VAL A 33 1 N ILE A 32 O ARG A 216 SHEET 3 AA1 5 LEU A 6 VAL A 9 1 N VAL A 8 O LEU A 31 SHEET 4 AA1 5 VAL A 237 TYR A 239 1 O VAL A 238 N VAL A 9 SHEET 5 AA1 5 VAL A 353 PHE A 355 1 O TYR A 354 N TYR A 239 SHEET 1 AA2 2 SER A 45 ALA A 47 0 SHEET 2 AA2 2 GLU A 54 HIS A 56 -1 O ILE A 55 N GLU A 46 SHEET 1 AA3 2 PHE A 63 THR A 65 0 SHEET 2 AA3 2 TYR A 192 GLY A 194 -1 O TYR A 192 N THR A 65 SHEET 1 AA4 7 THR A 94 GLN A 97 0 SHEET 2 AA4 7 PHE A 88 HIS A 91 -1 N HIS A 91 O THR A 94 SHEET 3 AA4 7 VAL A 276 TYR A 279 1 O ASN A 278 N MET A 90 SHEET 4 AA4 7 ARG A 288 GLU A 291 -1 O ILE A 289 N MET A 277 SHEET 5 AA4 7 THR A 308 PHE A 317 -1 O MET A 311 N HIS A 290 SHEET 6 AA4 7 TRP A 256 LEU A 266 -1 N THR A 258 O ARG A 316 SHEET 7 AA4 7 TYR A 326 PRO A 327 -1 O TYR A 326 N ARG A 257 SHEET 1 AA5 5 ILE B 213 ARG B 216 0 SHEET 2 AA5 5 VAL B 30 VAL B 33 1 N ILE B 32 O ARG B 216 SHEET 3 AA5 5 LEU B 6 VAL B 9 1 N VAL B 8 O LEU B 31 SHEET 4 AA5 5 VAL B 237 TYR B 239 1 O VAL B 238 N VAL B 9 SHEET 5 AA5 5 VAL B 353 PHE B 355 1 O TYR B 354 N VAL B 237 SHEET 1 AA6 2 SER B 45 ALA B 47 0 SHEET 2 AA6 2 GLU B 54 HIS B 56 -1 O ILE B 55 N GLU B 46 SHEET 1 AA7 2 PHE B 63 THR B 65 0 SHEET 2 AA7 2 TYR B 192 GLY B 194 -1 O TYR B 192 N THR B 65 SHEET 1 AA8 7 THR B 94 GLN B 97 0 SHEET 2 AA8 7 VAL B 87 HIS B 91 -1 N HIS B 91 O THR B 94 SHEET 3 AA8 7 VAL B 276 TYR B 279 1 O ASN B 278 N MET B 90 SHEET 4 AA8 7 ARG B 288 GLU B 291 -1 O ILE B 289 N MET B 277 SHEET 5 AA8 7 THR B 308 PHE B 317 -1 O GLU B 313 N ARG B 288 SHEET 6 AA8 7 TRP B 256 LEU B 266 -1 N LEU B 266 O THR B 308 SHEET 7 AA8 7 TYR B 326 PRO B 327 -1 O TYR B 326 N ARG B 257 SITE 1 AC1 2 ARG A 334 ARG A 341 SITE 1 AC2 7 GLN A 161 TRP A 162 ARG A 288 SER A 315 SITE 2 AC2 7 TYR A 326 PRO A 327 TYR A 364 SITE 1 AC3 32 GLY A 10 GLY A 12 LEU A 13 PHE A 14 SITE 2 AC3 32 VAL A 33 GLU A 34 LYS A 35 ARG A 36 SITE 3 AC3 32 GLY A 41 ASN A 42 TYR A 58 ALA A 60 SITE 4 AC3 32 HIS A 61 LEU A 62 THR A 219 ASP A 220 SITE 5 AC3 32 TRP A 221 PHE A 222 PRO A 242 TYR A 325 SITE 6 AC3 32 TYR A 326 GLY A 357 ARG A 358 TYR A 364 SITE 7 AC3 32 LEU A 365 ASP A 366 MET A 367 ALA A 370 SITE 8 AC3 32 HOH A 505 HOH A 507 HOH A 509 HOH A 514 SITE 1 AC4 3 ILE A 129 ASP A 130 SER A 131 SITE 1 AC5 1 ARG A 119 SITE 1 AC6 3 THR A 81 GLY A 82 GLU A 298 SITE 1 AC7 2 PRO A 304 LYS A 305 SITE 1 AC8 2 ARG B 334 ARG B 341 SITE 1 AC9 5 GLN B 161 SER B 315 TYR B 326 PRO B 327 SITE 2 AC9 5 TYR B 364 SITE 1 AD1 27 VAL B 9 GLY B 10 GLY B 12 LEU B 13 SITE 2 AD1 27 PHE B 14 VAL B 33 GLU B 34 LYS B 35 SITE 3 AD1 27 ARG B 36 GLY B 40 GLY B 41 ASN B 42 SITE 4 AD1 27 TYR B 58 ALA B 60 HIS B 61 LEU B 62 SITE 5 AD1 27 THR B 219 TRP B 221 PHE B 222 THR B 240 SITE 6 AD1 27 TYR B 325 GLY B 357 ARG B 358 TYR B 364 SITE 7 AD1 27 LEU B 365 ASP B 366 MET B 367 SITE 1 AD2 2 ASP B 130 SER B 131 SITE 1 AD3 1 ARG B 119 SITE 1 AD4 4 ARG B 36 SER B 37 HIS B 38 TYR B 58 SITE 1 AD5 2 ARG B 334 PHE B 338 SITE 1 AD6 2 GLU B 262 TYR B 314 CRYST1 179.362 179.362 145.236 90.00 90.00 120.00 P 64 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005575 0.003219 0.000000 0.00000 SCALE2 0.000000 0.006438 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006885 0.00000